What is NDC 51662-1591?

51662-1591 is the product NDC for Xylocaine, Lidocaine hydrochloride anhydrous 10 mg/mL injection, solution, listed with the FDA by HF Acquisition Co LLC, DBA HealthFirst. It has 1 package NDC, shown above in 10- and 11-digit form.

What is the active ingredient?

Lidocaine hydrochloride anhydrous.

HF Acquisition Co LLC, DBA HealthFirst, NDC labeler code 51662. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Xylocaine?

23 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Xylocaine NDC 51662-1591 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)51662-1591Labeler and product segments. Claims need a package NDC.

Product NDC at billing width51662-1591Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
51662-1591-3	5166215910351662159103	25 POUCH in 1 CASE (51662-1591-3) / 1 VIAL, MULTI-DOSE in 1 POUCH (51662-1591-2) / 20 mL in 1 VIAL, MULTI-DOSEMarketed from Jul 13, 2022

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Xylocaine
Generic name (nonproprietary): xylocaine
Active ingredients: Lidocaine hydrochloride anhydrous — 10 mg/mL
Dosage form: Injection, Solution
Route: Infiltration, Perineural
Labeler: HF Acquisition Co LLC, DBA HealthFirstNDC labeler code 51662
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 006488
Marketing start: Jul 13, 2022
Listing expires: Dec 31, 2026
Other FDA classes: Amides (Chemical structure)Local Anesthesia (Physiologic effect)
Identifiers: Product ID 51662-1591_08669a95-8c7b-9ad0-e063-6394a90adba2SPL ID 08669a95-8c7b-9ad0-e063-6394a90adba2SPL set ID e3b3b462-8f35-68b8-e053-2995a90a6403RxCUI 1010033UNII EC2CNF7XFP
Pharmacologic class: Amide Local Anesthetic; Antiarrhythmic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N451662159103 followed by a unit qualifier and the quantity

Package 51662-1591-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 27, 2024.

Indications (excerpt from the label)

INDICATIONS & USAGE Xylocaine (lidocaine HCl) Injections are indicated for production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks, when the accepted procedures for these techniques as described in standard textbooks are observed.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 51662-1591

What is NDC 51662-1591?: 51662-1591 is the product NDC for Xylocaine, Lidocaine hydrochloride anhydrous 10 mg/mL injection, solution, listed with the FDA by HF Acquisition Co LLC, DBA HealthFirst. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Xylocaine.
What is the active ingredient?: Lidocaine hydrochloride anhydrous.
Who is the labeler?: HF Acquisition Co LLC, DBA HealthFirst, NDC labeler code 51662. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Xylocaine?: 23 other product NDCs are listed under this name. See all Xylocaine NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Xylocaine NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Xylocainelidocaine hydrochloride,epinephrine bitartrate	Lidocaine hydrochloride anhydrous 10 mg/mL; Epinephrine bitartrate .01 mg/mL	Injection, SolutionInfiltration, Perineural	REMEDYREPACK INC.	70518-4152	70518-4152-0170518-4152-02
Xylocaine	Lidocaine hydrochloride anhydrous 20 mg/mL	Injection, SolutionInfiltration, Perineural	HF Acquisition Co LLC, DBA HealthFirst	51662-1590	51662-1590-03
Xylocainelidocaine hcl	Lidocaine hydrochloride anhydrous 20 mg/mL	Injection, SolutionInfiltration, Perineural	Henry Schein, Inc.	0404-9974	00404-9974-2000404-9974-50
Xylocainelidocaine hydrochloride and epinephrine	Lidocaine hydrochloride anhydrous 20 mg/mL; Epinephrine bitartrate .005 mg/mL	Injection, SolutionEpidural, Infiltration, Intracaudal, Perineural	Henry Schein, Inc.	0404-9972	00404-9972-20
Xylocainelidocaine hydrochloride	Lidocaine hydrochloride anhydrous 10 mg/mL	Injection, SolutionInfiltration, Perineural	Henry Schein, Inc.	0404-9973	00404-9973-2000404-9973-50
Xylocainelidocaine hydrochloride, epinephrine bitartrate injection, solution	Lidocaine hydrochloride anhydrous 5 mg/mL; Epinephrine bitartrate .005 mg/mL	Injection, SolutionInfiltration, Perineural	Henry Schein, Inc	0404-9975	00404-9975-50
Xylocainelidocaine hydrochloride and epinephrine	Lidocaine hydrochloride anhydrous 20 mg/mL; Epinephrine bitartrate .01 mg/mL	Injection, SolutionInfiltration, Perineural	Henry Schein, Inc.	0404-9976	00404-9976-2000404-9976-50
Xylocainelidocaine hydrochloride and epinephrine	Lidocaine hydrochloride anhydrous 10 mg/mL; Epinephrine bitartrate .01 mg/mL	Injection, SolutionInfiltration, Perineural	Henry Schein, Inc.	0404-9977	00404-9977-2000404-9977-50
Xylocainelidocaine hydrochloride,epinephrine bitartrate	Lidocaine hydrochloride anhydrous 20 mg/mL; Epinephrine bitartrate .01 mg/mL	Injection, SolutionInfiltration, Perineural	A-S Medication Solutions	50090-6851	50090-6851-00
Xylocaine	Epinephrine bitartrate .01 mg/mL; Lidocaine hydrochloride anhydrous 10 mg/mL	Injection, SolutionInfiltration, Perineural	HF Acquisition Co LLC, DBA HealthFirst	51662-1622	51662-1622-03

All 24 Xylocaine NDCs

Other NDCs under NDA 006488

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 006488
Product	Strength	Form · route	Labeler	Product NDC
Xylocainelidocaine hydrochloride and epinephrine	Lidocaine hydrochloride anhydrous 20 mg/mL; Epinephrine bitartrate .005 mg/mL	Injection, SolutionEpidural, Infiltration, Intracaudal, Perineural	Henry Schein, Inc.	0404-9972
XYLOCAINE- MPF (LIDOCAINE HCl )lidocaine hcl	Lidocaine hydrochloride anhydrous 20 mg/mL	Injection, SolutionEpidural, Infiltration, Intracaudal, Perineural	HF Acquisition Co LLC, DBA HealthFirst	51662-1604
Xylocaine	Epinephrine bitartrate .01 mg/mL; Lidocaine hydrochloride anhydrous 10 mg/mL	Injection, SolutionInfiltration, Perineural	HF Acquisition Co LLC, DBA HealthFirst	51662-1622
Xylocainelidocaine hydrochloride,epinephrine bitartrate	Lidocaine hydrochloride anhydrous 10 mg/mL; Epinephrine bitartrate .01 mg/mL	Injection, SolutionInfiltration, Perineural	Fresenius Kabi USA, LLC	63323-482
Xylocainelidocaine hydrochloride,epinephrine bitartrate	Lidocaine hydrochloride anhydrous 5 mg/mL; Epinephrine bitartrate .005 mg/mL	Injection, SolutionInfiltration, Perineural	Fresenius Kabi USA, LLC	63323-481
Xylocainelidocaine hydrochloride	Lidocaine hydrochloride anhydrous 10 mg/mL	Injection, SolutionInfiltration, Perineural	Fresenius Kabi USA, LLC	63323-485
Xylocainelidocaine hydrochloride,epinephrine bitartrate	Lidocaine hydrochloride anhydrous 10 mg/mL; Epinephrine bitartrate .01 mg/mL	Injection, SolutionInfiltration, Perineural	Fresenius Kabi USA, LLC	63323-482
Xylocainelidocaine hydrochloride,epinephrine bitartrate	Lidocaine hydrochloride anhydrous 20 mg/mL; Epinephrine bitartrate .01 mg/mL	Injection, SolutionInfiltration, Perineural	Fresenius Kabi USA, LLC	63323-483
Xylocainelidocaine hydrochloride	Lidocaine hydrochloride anhydrous 5 mg/mL	Injection, SolutionInfiltration, Perineural	Fresenius Kabi USA, LLC	63323-484
Xylocainelidocaine hydrochloride	Lidocaine hydrochloride anhydrous 10 mg/mL	Injection, SolutionInfiltration, Perineural	Fresenius Kabi USA, LLC	63323-485
Xylocainelidocaine hydrochloride	Lidocaine hydrochloride anhydrous 20 mg/mL	Injection, SolutionInfiltration, Perineural	Fresenius Kabi USA, LLC	63323-486
Xylocainelidocaine hydrochloride	Lidocaine hydrochloride anhydrous 20 mg/mL	Injection, SolutionInfiltration, Perineural	Fresenius Kabi USA, LLC	63323-486
Xylocaine MPFlidocaine hydrochloride	Lidocaine hydrochloride anhydrous 5 mg/mL	Injection, SolutionInfiltration	Fresenius Kabi USA, LLC	63323-491
Xylocaine MPFlidocaine hydrochloride	Lidocaine hydrochloride anhydrous 10 mg/mL; Epinephrine bitartrate .005 mg/mL	Injection, SolutionEpidural, Infiltration, Intracaudal, Perineural	Fresenius Kabi USA, LLC	63323-487
Xylocaine MPFlidocaine hydrochloride,epinephrine bitartrate	Lidocaine hydrochloride anhydrous 15 mg/mL; Epinephrine bitartrate .005 mg/mL	Injection, SolutionEpidural, Infiltration, Intracaudal, Perineural	Fresenius Kabi USA, LLC	63323-488
Xylocaine MPFlidocaine hydrochloride,epinephrine bitartrate	Lidocaine hydrochloride anhydrous 20 mg/mL; Epinephrine bitartrate .005 mg/mL	Injection, SolutionEpidural, Infiltration, Intracaudal, Perineural	Fresenius Kabi USA, LLC	63323-489
Xylocaine MPFlidocaine hydrochloride	Lidocaine hydrochloride anhydrous 15 mg/mL	Injection, SolutionEpidural, Infiltration, Intracaudal, Perineural	Fresenius Kabi USA, LLC	63323-493
Xylocaine Mpf	Lidocaine hydrochloride anhydrous 10 mg/mL	Injection, SolutionEpidural, Infiltration, Intracaudal, Perineural	HF Acquisition Co LLC, DBA HealthFirst	51662-1644
Xylocaine MPFlidocaine hydrochloride	Lidocaine hydrochloride anhydrous 10 mg/mL	Injection, SolutionEpidural, Infiltration, Intracaudal, Perineural	Fresenius Kabi USA, LLC	63323-492
Xylocaine	Lidocaine hydrochloride anhydrous 10 mg/mL	Injection, SolutionInfiltration, Perineural	HF Acquisition Co LLC, DBA HealthFirst	51662-1645

Showing 20 of 40.